Judith N. Wasserheit, MD, MPH
Department of Global Health
Adjunct Professor
Department of Epidemiology
William H. Foege Chair, UW Department of Global Health
Affiliate Investigator, Fred Hutchinson Cancer Research
Co-Director, UW Alliance for Pandemic Preparedness

Faculty Information


Judith N. Wasserheit, MD, MPH has worked extensively at the interface of STI and HIV clinical-epidemiological research, programs, and policy in the U.S. and globally. Currently the Chair and Professor of Global Health, Professor of Medicine and Adjunct Professor of Epidemiology at the University of Washington, she was the founding chief of the US NIH's STD Research Branch; Director of the US CDC's STD Prevention Program, and Director of the HIV Vaccine Trials Network, the largest global clinical trials platform evaluating preventive HIV vaccines. Her research has included one of the first laparoscopic studies of pelvic inflammatory disease etiology conducted in the US, the first population-based study of the prevalence and etiologic spectrum of STDs among rural women in the Indian Subcontinent, and research on the interrelationships between STDs and contraceptive practices in other parts of the developing world, including Indonesia and Egypt. She has also worked in Columbia, Thailand, and Zambia. Her development of the concept of epidemiological synergy between HIV infection and other STDs has had a major influence on HIV prevention policy and programs around the world.

Dr. Wasserheit has extensive experience working successfully with national and international agencies, governments, and colleagues on STD and HIV research, policy and programmatic issues. She has led or served on numerous World Health Organization and UNAIDS committees and advisory groups. Her many honors include the US DHHS Presidential Meritorious Rank Award, the Infectious Diseases Society of America's Edward E. Kass Award, and the American Social Health Association's Presidential Award. In 2006, she was elected to the Institute of Medicine of the National Academies of Science; in 2007, she was selected as a Paul Rogers Society Global Health Research Ambassador; and in 2009, she was honored as the London School of Hygiene and Tropical Medicine's Heath Clark Endowed Lecturer. In 2012, she assumed the Chair of the Board of Directors of the Consortium of Universities for Global Health.

Education & Training: 
Harvard Medical School
Boston MA
Johns Hopkins University School of Hygiene andPublic Health
Baltimore MD
Senior Residency
Emory University Hospitals
Atlanta GA
Research Fellowship in Infectious Diseases
University of Washington
Seattle WA
Phi Beta Kappa
Presidential Meritorious Rank Award
ASHA Presidential Award for outstanding work in the area of STD research
Top 300 Women Leaders in Global Health, Global Health Programme, Graduate Institute of International and Development Studies
(206) 685-1894
Mailing Address: 

Hans Rosling Center, Room 723

3980 15th Ave. NE; MS 351620

Seattle, WA 98195

Research & Clinical Interests
Research Interests: 

Current research interests include: mathematical modeling of the combined effects of biological co-factors such as HSV-2 infection, malaria and TB on HIV epidemic trajectory; designing and evaluating combination HIV prevention packages for sub-Saharan Africa; developing and evaluating multi-components interventions to reduce STDs, HIV and pregnancy among adolescents; and developing and evaluating approaches to adaptation to climate change to reduce the impact on human health.


Pfeiffer J, Beschta J, Hohl S, Gloyd S, Hagopian A, Wasserheit JN. Competency-based curricula to transform global health: redesign with the end in mind. Acad Med. 2013; 88(1):131-6.
• PubMed Abstract

Kirkcaldy RD, Bolan GA, Wasserheit JN. Cephalosporin-resistant gonorrhea in North America. JAMA. 2013; 309(2):185-7.
• JAMA Full-Text

Abu-Raddad LJ, Barnabas RV, Janes H, Kublin J, Longini IG, Weiss H, Wasserheit JN and the HIV Viral Load Working Group. Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? AIDS. 2013; 27(6):981-9.
• PubMed Abstract

Bolan GA, Sparling FP, Wasserheit JN. The emerging threat of untreatable gonococcal infection [Invited perspective]. N Engl J Med. 2012; 366:485-7.
PubMed Abstract

Moreno MA, Brockman LB, Wasserheit JA, Christakis DC. A pilot evaluation of older adolescents' sexual reference displays on Facebook. J Sex Res. 2012; 49(4):390-9.
• PubMed Abstract

Barnabas RV, Webb EL, Weiss HA, Wasserheit JN. The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS. 2011; 25:1559-73.
• PubMed Abstract

Hayes RJ, Watson-Jones D, Celum C, van de Wijgert J, Wasserheit JN. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS. 2010; 24 (Suppl 4):S15-26.
• PubMed Abstract

Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010; 24(5):621-35. 
• PubMed Abstract

Koplan JP, Bond TC, Merson MH, Reddy KS, Rodriguez MH, Sewankambo NK, Wasserheit JN for the Consortium of Universities for Global Health Executive Board. Towards a common definition of global health. Lancet. 2009; 373(9679):1993-5. 
• PubMed Abstract

Golden MR, Wasserheit JN. Prevention of viral sexually transmitted infections--foreskin at the forefront [Editorial]. N Engl J Med. 2009: 360(13):1349-51. 
• PubMed Abstract

Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Inf. 1999; 75:3-17.
• PubMed Abstract